Pharma.MT Ltd Competitors

PCI is a leading provider of integrated pharmaceutical development services to the global healthcare market. With facilities in North America and Europe, PCI supports pharmaceutical and biotech companies with products destined for more than 100 countries around the world. PCI provides services for each stage of the product lifecycle – from early Phase I through commercial launch and long-term supply – and partners with customers to provide key insight and expertise in enabling successful commercialization and bringing lifesaving medications to patients. For more information, go to www.pciservices.com.

AXIS Clinicals Limited is one of the most experienced and fastest growing Clinical Research Organization. Our state-of-the-art facilities houses 500+ dedicated full-time professionals to ensure the quick turn around time with high quality. Our facilities are accredited by DCGI (Drugs Controller General – India), NABL (National Accreditation Board for Testing and Calibration Laboratories - ISO 15189:2003) and inspected by US-FDA, UK-MHRA, Brazil-ANVISA, France –AFSSAPS / ANSM, GCC, MCC-South Africa etc. Within short span, we have achieved the milestone of completing 2750+ clinical studies and 1000+ product approvals from various regulatory agencies. 65+ regulatory audits from global competent authorities is testament to our professionalism and dedication to quality studies. Our Phase II – IV capabilities are growing along with an extended portfolio of Site Management, Medical Writing, and Data Management.

QCL is science driven, quality focused, and responsive. Privately held since inception in 1998, the owner-operator is a noted organic chemist, being fully engaged in the science, and leading the company in challenging problem solving situations for customers. We offer high quality analytical development, finished product and API testing, stability studies, raw materials testing, synthetic chemistry services, and microbiological testing services. Based in Wilmington, North Carolina, we are expanding capacity and capabilities recently building a 37,000 square foot laboratory and formulation development facility in 2017. QCL operates in compliance with cGMPs, is registered with FDA, and has had eight successful FDA inspections. QCL is also registered with DEA for controlled substance schedules 1 through 5.